Centessa Pharmaceuticals (CNTA) News Today $12.77 -0.10 (-0.78%) Closing price 05/27/2025 04:00 PM EasternExtended Trading$12.89 +0.12 (+0.94%) As of 04:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CNTA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Gregory M. Weinhoff Sells 10,000 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA) StockMay 28 at 5:07 AM | insidertrades.comMillennium Management LLC Raises Holdings in Centessa Pharmaceuticals plc (NASDAQ:CNTA)Millennium Management LLC lifted its holdings in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 73.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 398,451 sharesMay 28 at 3:43 AM | marketbeat.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Given Consensus Recommendation of "Buy" by AnalystsCentessa Pharmaceuticals plc (NASDAQ:CNTA - Get Free Report) has been assigned an average recommendation of "Buy" from the nine ratings firms that are covering the stock, Marketbeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 1-year price target among brokersMay 28 at 1:31 AM | marketbeat.comWoodline Partners LP Buys 29,266 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)Woodline Partners LP raised its stake in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 5.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 545,645 shares of the company's stock after buying an aMay 25 at 4:41 AM | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Upgraded at Wall Street ZenMay 25 at 3:57 AM | americanbankingnews.comLazard Asset Management LLC Takes Position in Centessa Pharmaceuticals plc (NASDAQ:CNTA)Lazard Asset Management LLC purchased a new position in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 73,189 shares of the compaMay 22, 2025 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap Up After Insider Buying ActivityMay 22, 2025 | americanbankingnews.comArjun Goyal Buys 417,646 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA) StockMay 21, 2025 | americanbankingnews.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Director Buys $550,053.36 in StockMay 20, 2025 | insidertrades.comLeerink Partnrs Has Positive Estimate for CNTA Q2 EarningsCentessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) - Analysts at Leerink Partnrs raised their Q2 2025 earnings estimates for Centessa Pharmaceuticals in a note issued to investors on Wednesday, May 14th. Leerink Partnrs analyst D. Risinger now forecasts that the company will earn ($0.35) peMay 20, 2025 | marketbeat.comCentessa Pharmaceuticals to Participate in Upcoming Investor ConferencesMay 19, 2025 | globenewswire.comPoint72 Asset Management L.P. Grows Stock Position in Centessa Pharmaceuticals plc (NASDAQ:CNTA)Point72 Asset Management L.P. lifted its position in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 26.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 3,426,599 shares of the company's stock after acquiring an additional 710,936 shaMay 18, 2025 | marketbeat.comWhat is Chardan Capital's Forecast for CNTA FY2025 Earnings?May 18, 2025 | americanbankingnews.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Shares Sold by Cubist Systematic Strategies LLCCubist Systematic Strategies LLC trimmed its holdings in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 65.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 45,885 shares of the company's stock after selling 88,235 sharesMay 17, 2025 | marketbeat.comJanus Henderson Group PLC Buys 3,614,623 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)Janus Henderson Group PLC boosted its stake in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 279.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,909,487 shares of the coMay 15, 2025 | marketbeat.comCentessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025May 14, 2025 | uk.finance.yahoo.comCentessa Pharmaceuticals plc: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025May 14, 2025 | finanznachrichten.deCentessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025May 14, 2025 | globenewswire.comBalyasny Asset Management L.P. Sells 505,993 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)Balyasny Asset Management L.P. lessened its position in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 74.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 175,428 shares of the compaMay 14, 2025 | marketbeat.comDZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Acquires New Stake in Centessa Pharmaceuticals plc (NASDAQ:CNTA)DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main bought a new position in Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 303,479 sMay 12, 2025 | marketbeat.comVoya Investment Management LLC Makes New Investment in Centessa Pharmaceuticals plc (NASDAQ:CNTA)Voya Investment Management LLC purchased a new stake in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 29,670 shares of the comMay 12, 2025 | marketbeat.comFarallon Capital Management LLC Acquires 684,391 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)Farallon Capital Management LLC raised its holdings in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 24.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,498,709 shares of the company's stockMay 11, 2025 | marketbeat.comDriehaus Capital Management LLC Sells 563,545 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)Driehaus Capital Management LLC lessened its holdings in Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 26.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,598,183 shares of the company's stock after sellingMay 11, 2025 | marketbeat.comChardan Capital Initiates Coverage on Centessa Pharmaceuticals (NASDAQ:CNTA)Chardan Capital began coverage on shares of Centessa Pharmaceuticals in a research note on Thursday. They set a "buy" rating and a $30.00 price objective for the company.May 10, 2025 | marketbeat.comDAFNA Capital Management LLC Has $795,000 Position in Centessa Pharmaceuticals plc (NASDAQ:CNTA)DAFNA Capital Management LLC cut its position in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 60.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 47,453 shares of the company's sMay 10, 2025 | marketbeat.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Shares Acquired by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company increased its stake in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 19.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 317,329 shares of the company's sMay 10, 2025 | marketbeat.comThis Centessa Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For ThursdayMay 8, 2025 | benzinga.comChardan Capital Initiates Coverage of Centessa Pharmaceuticals plc - Depositary Receipt () (CNTA) with Buy RecommendationMay 8, 2025 | msn.comCutter Capital Management LP Takes $2.46 Million Position in Centessa Pharmaceuticals plc (NASDAQ:CNTA)Cutter Capital Management LP bought a new position in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 147,076 shares of the company'sMay 8, 2025 | marketbeat.comCentessa Pharmaceuticals (CNTA) Expected to Announce Quarterly Earnings on MondayCentessa Pharmaceuticals (NASDAQ:CNTA) will be releasing its Q1 2025 earnings before the market opens on Monday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-12-centessa-pharmaceuticals-plc-american-depositary-shares-stock/)May 7, 2025 | marketbeat.comAvidity Partners Management LP Sells 966,200 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)Avidity Partners Management LP decreased its holdings in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 45.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,165,800 shares of tMay 6, 2025 | marketbeat.comIs Centessa Pharmaceuticals plc (CNTA) the Best Small Cap Stock to Buy with the Biggest Upside Potential?May 5, 2025 | insidermonkey.comAllostery Investments LP Makes New Investment in Centessa Pharmaceuticals plc (NASDAQ:CNTA)Allostery Investments LP acquired a new stake in Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 284,517 shares of the company's stock, valued at approximateMay 4, 2025 | marketbeat.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Shares Sold by Ally Bridge Group NY LLCAlly Bridge Group NY LLC cut its holdings in Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 21.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 244,538 shares of the company's stock afterMay 4, 2025 | marketbeat.com5AM Venture Management LLC Cuts Stock Position in Centessa Pharmaceuticals plc (NASDAQ:CNTA)5AM Venture Management LLC cut its holdings in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 35.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 830,945 shares of the company's stock aMay 4, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Acquires Shares of 365,200 Centessa Pharmaceuticals plc (NASDAQ:CNTA)Schonfeld Strategic Advisors LLC bought a new stake in Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 365,200 shares of the company's stock, valued at approximately $6,117,000.May 4, 2025 | marketbeat.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Given Average Recommendation of "Buy" by BrokeragesCentessa Pharmaceuticals plc (NASDAQ:CNTA - Get Free Report) has received a consensus recommendation of "Buy" from the eight brokerages that are currently covering the stock, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy rating. The average 1 year price target among anMay 4, 2025 | marketbeat.comBoothbay Fund Management LLC Invests $702,000 in Centessa Pharmaceuticals plc (NASDAQ:CNTA)Boothbay Fund Management LLC purchased a new stake in Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 41,900 shares of the company's stock, valued atMay 2, 2025 | marketbeat.comFirst Light Asset Management LLC Sells 134,948 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)First Light Asset Management LLC trimmed its holdings in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 2.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,805,184 shares of the company's stock after selling 134,948 sharApril 30, 2025 | marketbeat.com1,253,379 Shares in Centessa Pharmaceuticals plc (NASDAQ:CNTA) Acquired by Foresite Capital Management VI LLCForesite Capital Management VI LLC bought a new stake in Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 1,253,379 shares of the company's stock, valued at approximately $20,994,April 30, 2025 | marketbeat.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Shares Acquired by Lord Abbett & CO. LLCLord Abbett & CO. LLC lifted its position in Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 63.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 440,495 shares of the company's stock after purcApril 30, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Raises Holdings in Centessa Pharmaceuticals plc (NASDAQ:CNTA)Price T Rowe Associates Inc. MD increased its position in Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 14.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 5,364,392 shares of the company's stock after acquiring an additional 685,3April 30, 2025 | marketbeat.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) General Counsel Iqbal J. Hussain Sells 2,080 SharesApril 30, 2025 | insidertrades.comMarshall Wace LLP Lowers Position in Centessa Pharmaceuticals plc (NASDAQ:CNTA)Marshall Wace LLP reduced its stake in Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 22.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 139,732 shares of the company's stock after selling 41,121 shares during the periodApril 29, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Reduces Position in Centessa Pharmaceuticals plc (NASDAQ:CNTA)T. Rowe Price Investment Management Inc. lowered its position in Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 3.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,418,600 shares of the coApril 28, 2025 | marketbeat.comLegal & General Group Plc Buys Shares of 75,451 Centessa Pharmaceuticals plc (NASDAQ:CNTA)Legal & General Group Plc purchased a new position in Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 75,451 shares of the company's stocApril 28, 2025 | marketbeat.comJump Financial LLC Sells 23,411 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)Jump Financial LLC cut its stake in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 47.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 25,700 shares of the company's stock after selApril 27, 2025 | marketbeat.comBlue Owl Capital Holdings LP Decreases Stake in Centessa Pharmaceuticals plc (NASDAQ:CNTA)Blue Owl Capital Holdings LP cut its holdings in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 13.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 220,000 shares of the companApril 26, 2025 | marketbeat.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Shares Bought by Adage Capital Partners GP L.L.C.Adage Capital Partners GP L.L.C. increased its stake in Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 22.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,119,027 shares of the company's stock after buyinApril 26, 2025 | marketbeat.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Insider Gregory M. Weinhoff Sells 11,742 SharesApril 26, 2025 | insidertrades.com Get Centessa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTA and its competitors with MarketBeat's FREE daily newsletter. Email Address CNTA Media Mentions By Week CNTA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNTA News Sentiment▼1.001.03▲Average Medical News Sentiment CNTA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNTA Articles This Week▼95▲CNTA Articles Average Week Get Centessa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BPMC News BBIO News VRNA News TLX News TGTX News GRFS News LNTH News AXSM News NUVL News LEGN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNTA) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredDo You Believe In President Trump? Answer This 1 QuestionThey said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Centessa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CNTA Stock Free CNTA Stock Alerts